connection error: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
SELECT s_id FROM sessions WHERE s_id='0XZlxEEKS6BE3Vfg7Io3' LIMIT 1
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
INSERT INTO sessions ( s_id, s_lastact, s_ip ) VALUES ( '0XZlxEEKS6BE3Vfg7Io3', '1736837473', '18.97.14.84' )
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
SELECT s_id FROM sessvalues WHERE s_id='0XZlxEEKS6BE3Vfg7Io3' AND sv_name='_current' LIMIT 1
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
INSERT INTO sessvalues ( s_id, sv_name, sv_value ) VALUES ( '0XZlxEEKS6BE3Vfg7Io3', '_current', 'elizabethrx.com/feed?feed=fda' )
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
SELECT s_id AS id FROM sessions WHERE s_lastact < 1736823473
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
SELECT s_id FROM sessions WHERE s_id='06qmrUAK55OGPYOMwWA3' LIMIT 1
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
SELECT s_id FROM sessvalues WHERE s_id='0XZlxEEKS6BE3Vfg7Io3' AND sv_name='noexpire_str' LIMIT 1
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
INSERT INTO sessvalues ( s_id, sv_name, sv_value ) VALUES ( '0XZlxEEKS6BE3Vfg7Io3', 'noexpire_str', '18.97.14.84::06qmrUAK55OGPYOMwWA3' )
: php_network_getaddresses: getaddrinfo failed: Name or service not knownconnection error: php_network_getaddresses: getaddrinfo failed: Name or service not knownconnection error: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
SELECT s_id FROM sessions WHERE s_id='00kftqLVU9SrlKVKabyJ' LIMIT 1
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
INSERT INTO sessions ( s_id, s_lastact, s_ip ) VALUES ( '00kftqLVU9SrlKVKabyJ', '1736837473', '18.97.14.84' )
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
SELECT s_id FROM sessvalues WHERE s_id='00kftqLVU9SrlKVKabyJ' AND sv_name='_current' LIMIT 1
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
INSERT INTO sessvalues ( s_id, sv_name, sv_value ) VALUES ( '00kftqLVU9SrlKVKabyJ', '_current', 'elizabethrx.com/feed?feed=fda' )
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
SELECT s_id AS id FROM sessions WHERE s_lastact < 1736823473
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
SELECT s_id FROM sessions WHERE s_id='0oVVEFXrHvwvqAO6tgXJ' LIMIT 1
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
SELECT s_id FROM sessvalues WHERE s_id='00kftqLVU9SrlKVKabyJ' AND sv_name='noexpire_str' LIMIT 1
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
INSERT INTO sessvalues ( s_id, sv_name, sv_value ) VALUES ( '00kftqLVU9SrlKVKabyJ', 'noexpire_str', '18.97.14.84::0oVVEFXrHvwvqAO6tgXJ' )
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
SELECT s_id FROM sessions WHERE s_id='0Fl2M8aAMj77JtzXfpCq' LIMIT 1
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
SELECT s_id FROM sessvalues WHERE s_id='00kftqLVU9SrlKVKabyJ' AND sv_name='noexpire_str' LIMIT 1
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
INSERT INTO sessvalues ( s_id, sv_name, sv_value ) VALUES ( '00kftqLVU9SrlKVKabyJ', 'noexpire_str', '18.97.14.84::0Fl2M8aAMj77JtzXfpCq' )
: php_network_getaddresses: getaddrinfo failed: Name or service not knownconnection error: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
SELECT s_id FROM sessions WHERE s_id='0JrjdtzfJaDF9n5dXNF8' LIMIT 1
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
INSERT INTO sessions ( s_id, s_lastact, s_ip ) VALUES ( '0JrjdtzfJaDF9n5dXNF8', '1736837473', '18.97.14.84' )
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
SELECT s_id FROM sessvalues WHERE s_id='0JrjdtzfJaDF9n5dXNF8' AND sv_name='_current' LIMIT 1
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
INSERT INTO sessvalues ( s_id, sv_name, sv_value ) VALUES ( '0JrjdtzfJaDF9n5dXNF8', '_current', 'elizabethrx.com/feed?feed=fda' )
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
SELECT s_id AS id FROM sessions WHERE s_lastact < 1736823473
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
SELECT s_id FROM sessions WHERE s_id='09pnwgjQFYM2O9jIbOeo' LIMIT 1
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
SELECT s_id FROM sessvalues WHERE s_id='0JrjdtzfJaDF9n5dXNF8' AND sv_name='noexpire_str' LIMIT 1
: php_network_getaddresses: getaddrinfo failed: Name or service not knowninvalid query:
INSERT INTO sessvalues ( s_id, sv_name, sv_value ) VALUES ( '0JrjdtzfJaDF9n5dXNF8', 'noexpire_str', '18.97.14.84::09pnwgjQFYM2O9jIbOeo' )
: php_network_getaddresses: getaddrinfo failed: Name or service not known
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
http://www.fda.gov/news-events/press-announcements/fda-roundup-january-10-2025The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
http://www.fda.gov/news-events/press-announcements/fda-roundup-january-7-2025The FDA issued draft guidance that, when finalized, will provide recommendations for including tissue biopsies as part of clinical trials evaluating investigational medical products and/or that are conducted or supported by the Department of Health and Human Services.
http://www.fda.gov/news-events/press-announcements/fda-issues-draft-guidance-including-tissue-biopsies-clinical-trialsThe FDA issued draft guidance to provide recommendations on the use of artificial intelligence (AI) intended to support a regulatory decision about a drug or biological product’s safety, effectiveness or quality.
http://www.fda.gov/news-events/press-announcements/fda-proposes-framework-advance-credibility-ai-models-used-drug-and-biological-product-submissionsToday, the U.S. Food and Drug Administration issued draft guidance that includes recommendations to support development and marketing of safe and effective AI-enabled devices throughout the device’s Total Product Life Cycle.
http://www.fda.gov/news-events/press-announcements/fda-issues-comprehensive-draft-guidance-developers-artificial-intelligence-enabled-medical-devicesThe FDA published new draft guidance aimed at helping improve the accuracy and performance of pulse oximeters – important devices for patient care used to estimate the amount of oxygen carried in the blood – across the range of skin pigmentation.
http://www.fda.gov/news-events/press-announcements/fda-proposes-updated-recommendations-help-improve-performance-pulse-oximeters-across-skin-tonesThe U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
http://www.fda.gov/news-events/press-announcements/fda-roundup-january-3-2025The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-27-2024FDA announced a proposed rule to establish and require standardized testing methods to detect and identify asbestos in talc-containing cosmetic products
http://www.fda.gov/news-events/press-announcements/fda-proposes-rule-require-standardized-testing-methods-detecting-and-identifying-asbestos-talcFDA approved the first generic referencing Victoza (liraglutide injection) 18 mg/3 mL, a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes as an adjunct to diet and exercise.
http://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-once-daily-glp-1-injection-lower-blood-sugar-patients-type-2-diabetesToday, the FDA approved the first medication for the treatment of moderate to severe obstructive sleep apnea in adults with obesity, to be used in combination with a reduced-calorie diet and increased physical activity.
http://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apneaThe U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-20-2024FDA approved Symvess, the first acellular tissue engineered vessel for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible.
http://www.fda.gov/news-events/press-announcements/fda-approves-first-acellular-tissue-engineered-vessel-treat-vascular-trauma-extremitiesFDA announced a final rule to update the definition of the nutrient content claim “healthy” marking an important step in the agency’s nutrition priorities, which are part of a broader, whole-of-government approach to help address an ever-growing epidemic of preventable diet-related chronic diseases.
http://www.fda.gov/news-events/press-announcements/fda-updates-healthy-claim-providing-refreshed-tool-consumersFDA approves Ryoncil, the first mesenchymal stromal cell (MSC) therapy for treatment of steroid-refractory acute graft-versus-host disease (SR-a GVHD) in pediatric patients 2 months of age and older.
http://www.fda.gov/news-events/press-announcements/fda-approves-first-mesenchymal-stromal-cell-therapy-treat-steroid-refractory-acute-graft-versus-hostThe U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-17-2024Today, the FDA approved a new treatment to be used together with glucocorticoids (steroids) to control androgen (a testosterone-like hormone) levels in adults and pediatric patients 4 years of age and older with classic congenital adrenal hyperplasia.
http://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-congenital-adrenal-hyperplasiaThe U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-13-2024The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-10-2024The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-6-2024The views and opinions expressed in this feed are those of the authors and do not necessarily reflect the official policy or position of Elizabeth Pharmacy. Elizabeth Pharmacy does not warrant the accuracy, timeliness or completeness of the information contained on this feed. If you have a particular complaint about something you’ve found on this web site, feel free to contact us.